Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes:: a large European study

被引：26

作者：

Amaral, MD

Pacheco, P

Beck, S

Farinha, CM

Penque, D

Nogueira, P

Barreto, C

Lopes, B

Casals, T

Dapena, J

Gartner, S

Vásquez, C

Pérez-Frías, J

Olveira, C

Cabanas, R

Estivill, X

Tzetis, M

Kanavakis, E

Doudounakis, S

Dörk, T

Tümmler, B

Girodon-Boulandet, E

Cazeneuve, C

Goossens, M

Blayau, M

Verlingue, C

Vieira, I

Féréc, C

Claustres, M

des Georges, M

Clavel, C

Birembaut, P

Hubert, D

Bienvenu, T

Adoun, M

Chomel, JC

De Boeck, K

Cuppens, H

Lavinha, J

机构：

[1] Inst Nacl Saude Dr Ricardo Jorge, Ctr Human Genet, P-1649016 Lisbon, Portugal

[2] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, P-1699 Lisbon, Portugal

[3] Inst Nacl Saude Dr Ricardo Jorge, Observ Nacl Saude, P-1649016 Lisbon, Portugal

[4] Hosp Santa Maria, Serv Pediat, Unidade Fibrose Quist, Lisbon, Portugal

[5] Hosp D Estefania, Lisbon, Portugal

[6] Hosp Duran I Reynals, IRO, Dept Mol Genet, Barcelona, Spain

[7] Hosp Univ Virgen Roccio, Cyst Fibrosis Unit, Seville, Spain

[8] Hosp Univ Materno Infantil Vall Hebron, Cyst Fibrosis Unit, Barcelona, Spain

[9] Hosp Infantil Cruces, Cyst Fibrosis Unit, Pais Vasco, Spain

[10] Hosp Carlos Haya, Cyst Fibrosis Unit, Malaga, Spain

[11] Hosp Xeral Vigo, Paediat Serv, Galicia, Spain

[12] St Sophia Childrens Hosp, Dept Paediat 1, Athens, Greece

[13] St Sophia Childrens Hosp, Choremio Res Lab, Mol Med Unit, Athens, Greece

[14] Hannover Med Sch, Klin Forsch Grp, Hannover, Germany

[15] Hop Henri Mondor, Serv Biochim & genet, F-94010 Creteil, France

[16] CHRU Rennes Pontchaillou, Serv Genet Mol & Hormonol, Rennes, France

[17] CHU Brest, Lab Genet Mol & Histocompatibil, F-29285 Brest, France

[18] Inst Biol, Lab Genet Mol & Chromosom, Montpellier, France

[19] CHU Reims, Lab Pol Bouin, Reims, France

[20] CHU Reims, Hop Maison Blanche, INSERM, Unite U514, Reims, France

[21] Grp Hosp Cochin, Lab Biochim & Biol Mol, Paris, France

[22] Grp Hosp Cochin, Serv Pneumol, Paris, France

[23] CHU Poitiers, Lab Genet Cellulaire & Mol, Poitiers, France

[24] UZ Gasthuisberg, Dept Paediat, Louvain, Belgium

[25] Katholieke Univ Leuven, Ctr Human Genet, B-3001 Louvain, Belgium

来源：

JOURNAL OF MEDICAL GENETICS | 2001年 / 38卷 / 11期

关键词：

D O I：

10.1136/jmg.38.11.777

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：777 / 782

页数：6

共 39 条

[11] Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes - The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation [J].

Cuppens, H ;

Lin, W ;

Jaspers, M ;

Costes, B ;

Teng, H ;

Vankeerberghen, A ;

Jorissen, M ;

Droogmans, G ;

Reynaert, I ;

Goossens, M ;

Nilius, B ;

Cassiman, JJ .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :487-496

[12] CFTR HAPLOTYPE BACKGROUNDS ON NORMAL AND MUTANT CFTR GENES [J].

CUPPENS, H ;

TENG, H ;

RAEYMAEKERS, P ;

DEBOECK, C ;

CASSIMAN, JJ .

HUMAN MOLECULAR GENETICS, 1994, 3 (04) :607-614

[13] INTRAGENIC AND EXTRAGENIC MARKER HAPLOTYPES OF CFTR MUTATIONS IN CYSTIC-FIBROSIS FAMILIES [J].

DORK, T ;

NEUMANN, T ;

WULBRAND, U ;

WULF, B ;

KALIN, N ;

MAASS, G ;

KRAWCZAK, M ;

GUILLERMIT, H ;

FEREC, C ;

HORN, G ;

KLINGER, K ;

KEREM, BS ;

ZIELENSKI, J ;

TSUI, LC ;

TUMMLER, B .

HUMAN GENETICS, 1992, 88 (04) :417-425

[14] FLUORESCENCE-BASED OLIGONUCLEOTIDE LIGATION ASSAY FOR ANALYSIS OF CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE-MUTATIONS [J].

EGGERDING, FA ;

IOVANNISCI, DM ;

BRINSON, E ;

GROSSMAN, P ;

WINNDEEN, ES .

HUMAN MUTATION, 1995, 5 (02) :153-165

[15] MOLECULAR CHARACTERIZATION OF CYSTIC-FIBROSIS - 16 NOVEL MUTATIONS IDENTIFIED BY ANALYSIS OF THE WHOLE CYSTIC-FIBROSIS CONDUCTANCE TRANSMEMBRANE REGULATOR (CFTR) CODING REGIONS AND SPLICE SITE JUNCTIONS [J].

FANEN, P ;

GHANEM, N ;

VIDAUD, M ;

BESMOND, C ;

MARTIN, J ;

COSTES, B ;

PLASSA, F ;

GOOSSENS, M .

GENOMICS, 1992, 13 (03) :770-776

[16] beta-thalassemia mutation at -90C->T impairs the interaction of the proximal CACCC box with both erythroid and nonerythroid factors [J].

Faustino, P ;

Lavinha, J ;

Marini, MG ;

Moi, P .

BLOOD, 1996, 88 (08) :3248-3249

[17]

FERRIE RM, 1992, AM J HUM GENET, V51, P251

[18]

Friedman KJ, 1997, HUM MUTAT, V10, P108, DOI 10.1002/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.0.CO

[19]

2-G

[20] The prevalence of nasal polyps in adults with cystic fibrosis [J].

Hadfield, PJ ;

Rowe-Jones, JM ;

Mackay, IS .

CLINICAL OTOLARYNGOLOGY, 2000, 25 (01) :19-22

← 1 2 3 4 →

Cystic fibrosis patients with the 3272-26A&gt;G splicing mutation have milder disease than F508del homozygotes:: a large European study

Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes:: a large European study